Prescient Therapeutics announced the appointment of physician-scientist, Dr Marco Davila of the Moffitt Cancer Center (Moffitt) and bioengineering expert Professor Andrew Tsourkas of the University of Pennsylvania (Penn) to its Scientific Advisory Board (SAB). Dr Davila and Professor Tsourkas bring deep, complementary expertise to Prescient and join a highly credentialed SAB also comprising CAR-T expert Professor Phil Darcy; hematologist and CAR-T researcher Professor H. Miles Prince AM; and brain cancer specialist and cell therapy researcher Professor Don O'Rourke. Dr. Marco Davila is a medical oncologist in the Department of Blood and Marrow Transplantation at the Moffitt Cancer Center.